Genetic variation of the Bovine Leukemia Virus (BLV) appears to be lim
ited in vitro and during the latent phase of the disease. However, cel
ls in tumors often harbor deleted proviruses that are defective for ex
pression. In order to gain insight into the involvement of viral genet
ic variation during pathogenesis, the BLV LTR and the env proviral seq
uences were analyzed in tumor tissues. A sheep (M230) was injected wit
h the cloned BLV provirus 344 and became persistently infected with ci
rculating lymphocytes reaching 345,000/mm(3). After 11 months, this in
fected sheep developed leukemia-lymphoma. DNA was extracted from perip
heral blood leukocytes al the time of tumor development and the LTR an
d the env gene were amplified, using the polymerase chain reaction pro
cedure, cloned, and sequenced. Twenty independent LTR and twenty env c
lones were analyzed. It appeared that the in vivo mutation rate in the
env gene was 0.043% (eight mutations including seven transitions out
of 18,300 bp). Five point mutations (all transitions) were identified
in the LTR, corresponding to 0.041% modifications (four mutations out
of 9740 bp). These mutation rate values (0.043 and 0.041) were close t
o those due to the Tag DNA polymerase errors (0.030%). Altogether, the
se data demonstrate the lack of genetic variation in the LTR and the e
nv gene during this case of BLV-induced pathogenesis in vivo. They con
firm that the defectiveness of some BLV proviruses in vivo, thus, is n
ot a mandatory step in the leukemogenic process. (C) 1995 Academic Pre
ss, Inc.